Figure 6.

Two prognostic signatures, LASiglnc-9 and LASiglnc2-m3, lung adenocarcinoma outcome. (A) The ROC curve for 5-year overall survival prediction using the LASiglnc-9 signature. (B) The Kaplan-Meier curve of the risk score for the overall survival using the LASiglnc-9 signature; the log-rank test was used to compare the difference between low- and high-risk groups. (C) The ROC curve for predicting 5-year survival using the LASiglnc2-m3 signature. (D) The Kaplan-Meier curve of the risk score for the overall survival using the LASiglnc2-m3 signature. ROC, receiver operating characterstic; AUC, area under the curve.